Clinical pharmacology: Concise drug reviews

被引：26

作者：

De Kogel, Christine E. ^{[2
]}

Schellens, Jan H. M. ^{[1
,2
]}

机构：

[1] Netherlands Canc Inst, Dept Med Oncol, Div Clin Pharmacol, NL-1066 CX Amsterdam, Netherlands

[2] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Sect Biomed Anal,Div Drug Toxicol, Utrecht, Netherlands

来源：

ONCOLOGIST | 2007年 / 12卷 / 12期

关键词：

D O I：

10.1634/theoncologist.12-12-1390

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1390 / 1394

页数：5

共 13 条

[1] Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug [J].

Capdeville, R ;

Buchdunger, E ;

Zimmermann, J ;

Matter, A .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :493-502

[2] The development of imatinib as a therapeutic agent for chronic myeloid leukemia [J].

Deininger, M ;

Buchdunger, E ;

Druker, BJ .

BLOOD, 2005, 105 (07) :2640-2653

[3] Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas [J].

Desjardins, Annick ;

Quinn, Jennifer A. ;

Vredenburgh, James J. ;

Sathornsumetee, Sith ;

Friedman, Allan H. ;

Herndon, James E. ;

McLendon, Roger E. ;

Provenzale, James M. ;

Rich, Jeremy N. ;

Sampson, John H. ;

Gururangan, Sridharan ;

Dowell, Jeannette M. ;

Salvado, August ;

Friedman, Henry S. ;

Reardon, David A. .

JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (01) :53-60

[4] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].

Druker, Brian J. ;

Guilhot, Francois ;

O'Brien, Stephen G. ;

Gathmann, Insa ;

Kantarjian, Hagop ;

Gattermann, Norbert ;

Deininger, Michael W. N. ;

Silver, Richard T. ;

Goldman, John M. ;

Stone, Richard M. ;

Cervantes, Francisco ;

Hochhaus, Andreas ;

Powell, Bayard L. ;

Gabrilove, Janice L. ;

Rousselot, Philippe ;

Reiffers, Josy ;

Cornelissen, Jan J. ;

Hughes, Timothy ;

Agis, Hermine ;

Fischer, Thomas ;

Verhoef, Gregor ;

Shepherd, John ;

Saglio, Giuseppe ;

Gratwohl, Alois ;

Nielsen, Johan L. ;

Radich, Jerald P. ;

Simonsson, Bengt ;

Taylor, Kerry ;

Baccarani, Michele ;

So, Charlene ;

Letvak, Laurie ;

Larson, Richard A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417

[5] Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib [J].

Gardner, Erin R. ;

Burger, Herman ;

van Schaik, Ron H. ;

van Oosterom, Allan T. ;

de Bruijn, Ernst A. ;

Guetens, Gunther ;

Prenen, Hans ;

de Jong, Floris A. ;

Baker, Sharyn D. ;

Bates, Susan E. ;

Figg, William D. ;

Verweij, Jaap ;

Sparreboom, Alex ;

Nooter, Kees .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (02) :192-201

[6] Imatinib disposition and ABCB1 (MDR1, p-glycoprotein) genotype [J].

Gurney, H. ;

Wong, M. ;

Balleine, R. L. ;

Rivory, L. P. ;

McLachlan, A. J. ;

Hoskins, J. M. ;

Wilcken, N. ;

Clarke, C. L. ;

Mann, G. J. ;

Collins, M. ;

Delforce, S-E ;

Lynch, K. ;

Schran, H. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (01) :33-40

[7] Molecular correlates of imatinib resistance in gastrointestinal stromal tumors [J].

Heinrich, Michael C. ;

Corless, Christopher L. ;

Blanke, Charles D. ;

Demetri, George D. ;

Joensuu, Heikki ;

Roberts, Peter J. ;

Eisenberg, Burton L. ;

von Mehren, Margaret ;

Fletcher, Christopher D. M. ;

Sandau, Katrin ;

McDougall, Karen ;

Ou, Wen-bin ;

Chen, Chang-Jie ;

Fletcher, Jonathan A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4764-4774

[8] Molecular and chromosomal mechanisms of resistance to imatinib (ST1571) therapy [J].

Hochhaus, A ;

Kreil, S ;

Corbin, AS ;

La Rosée, P ;

Müller, MC ;

Lahaye, T ;

Hanfstein, B ;

Schoch, C ;

Cross, N ;

Berger, U ;

Gschaidmeier, H ;

Druker, BJ ;

Hehlmann, R .

LEUKEMIA, 2002, 16 (11) :2190-2196

[9] G1 cell-cycle control and cancer [J].

Massagué, J .

NATURE, 2004, 432 (7015) :298-306

[10] Clinical pharmacokinetics of imatinib [J].

Peng, B ;

Lloyd, P ;

Schran, H .

CLINICAL PHARMACOKINETICS, 2005, 44 (09) :879-894

← 1 2 →